| 摘要 |
FIELD: medicine, pharmaceutics.SUBSTANCE: invention refers to a new compound of 2-[3-(2,2-difluorobenzo[1,3]dioxol-5-ylamino)-5-(2,6-dimethylpyridin-4-yl)-[1,2,4]triazol4-yl]-N-ethylacetamide and/or pharmaceutically acceptable salts, or hydrate, or solvates, as well as to a method for preparing it; a pharmaceutical composition based on this compound and using its in therapy for prevention and treatment of mental disorders, intellectual disorders or diseases, inflammatory diseases or conditions wherein ?7 nicotinic receptor modulation is considered to be favourable. The invention also refers to a product containing such compound and ?7-nicotinic receptor agonist.EFFECT: preparing the compounds applicable in therapy for prevention or treatment of mental disorders, intellectual disorders or diseases, inflammatory diseases or conditions wherein ?7 nicotinic receptor modulation is considered to be favourable.6 cl, 1 tbl, 4 ex |
